Evidence map›Paper›PMID 34880166›Full record

ArticleJournal of atherosclerosis and thrombosis2022

CXCL1-Triggered PAD4 Cytoplasmic Translocation Enhances Neutrophil Adhesion through Citrullination of PDIA1.

Jiro Aoyama, Mizuko Osaka, Michiyo Deushi, Shoichi Hosoya, Akihito Ishigami, Taketoshi Maehara, Masayuki Yoshida

Open access · diamondAbstract read
In one paragraph

Article in Journal of atherosclerosis and thrombosis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Exploring Neutrophil Extracellular Traps in Cardiovascular Pathologies: The Impact of Lipid Profiles, PAD4, and Radiation.Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al · 2025
    Article
  3. Neutrophil extracellular traps: a catalyst for atherosclerosis.Molecular and cellular biochemistry · 2024
    Review
  4. Review
  5. Neutrophil attachment via Mac-1 (Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Article
  6. Targeting Inflammation is a Double-Edged Sword. Is PDIA1 A Key?Journal of atherosclerosis and thrombosis · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jiro AoyamaDepartment of Life Science and Bioethics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University.
Mizuko OsakaDepartment of Life Science and Bioethics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University.
Michiyo DeushiDepartment of Life Science and Bioethics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University.
Shoichi HosoyaResearch Core, Research Facility Cluster, Institute of Research, Tokyo Medical and Dental University.
Akihito IshigamiResearch Team for Functional Biogerontology, Tokyo Metropolitan Institute of Gerontology.
Taketoshi MaeharaDepartment of Neurosurgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University.
Masayuki YoshidaDepartment of Life Science and Bioethics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University.
Tokyo Medical and Dental University · JPTokyo Metropolitan Institute of Gerontology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsVascular inflammation is critical for the development and progression of atherosclerosis. Previously, we reported that neutrophils adhere to the vascular endothelium in low-density lipoprotein receptor null mice fed a high-fat diet through hypercitrullination of histone H3 by peptidylarginine deiminase 4 (PAD4) in neutrophils. However, the involvement of PAD4 and citrullination of proteins other than histone H3 in neutrophil adhesion is not well known. In this study, we investigated the function of PAD4 and identified citrullinated proteins during vascular inflammation.

methodsWe pefformed flow assay under physiological flow conditions using differentiated HL-60 (dHL-60) cells stimulated with CXCL1 and human umbilical vein endothelial cells (HUVECs). Furthermore, phalloidin stain for dHL-60 stimulated with CXCL1 to observe F-actin polymerization and immunohistochemistry for the activated β2-integrin was conducted. To identify a target of citrullination in the cytoplasm of dHL-60 cells, liquid chromatography-mass spectrometry (LC-MS/MS) for dHL-60 stimulated with CXCL1 was performed.

resultsInhibition or knockdown of PAD4 significantly decreased adhesion of under physiological flow conditions. Thr-Asp-F-amidine trifluoroacetate salt (TDFA), a PAD4 inhibitor, inhibited cytoplasmic translocation of PAD4 by CXCL1. TDFA or knockdown of PAD4 significantly decreased expression of β2-integrin and F-actin polymerization activated by CXCL1. Moreover, LC-MS/MS identified protein disulfide isomerase A1 (PDIA1) as a target of citrullination in the cytoplasm of dHL-60 cells. Knockdown of PDIA1 significantly decreased adhesion of dHL-60 cells to HUVECs, expression of β2-integrin, and F-actin polymerization.

conclusionsCytoplasmic translocation of PAD4 by CXCL1 induces neutrophil adhesion to vascular endothelial cells and citrullination of PDIA1.

Indexed as

CitrullinationNeutrophilsActinsAnimalsChemokine CXCL1Chromatography, LiquidCytoplasmEndothelial CellsHistonesHumansInflammationIntegrinsMiceProtein-Arginine Deiminase Type 4Protein Disulfide-IsomerasesTandem Mass SpectrometryActinsChemokine CXCL1CXCL1 protein, humanHistonesIntegrinsProtein-Arginine Deiminase Type 4Protein Disulfide-IsomerasesCitrullinationNeutrophilPAD4Vascular inflammation

Identifiers

PMID34880166
PMCPMC9444809
OpenAlexW4200026329

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.